Table 1.
Patient details.
| Demographics | Group 1 Weight Stable (n = 9) |
Group 2 ≥5% Weight Loss (n = 9) |
p Values |
|---|---|---|---|
| Male: Female | 8:1 | 5:4 | N/A |
| Age (years) | 61 (4.65) | 66 (10.53) | 0.167 |
| % Weight loss | 2.13 (1.35) | 14.39 (6.56) | 0.001 * |
| SMI | 47.17 (6.26) | 45.82 (7.72) | 0.536 |
| SATI | 46.25 (20.38) | 58.43 (33.86) | 0.379 |
| VATI | 57.57 (55.28) | 42.10 (33.48) | 0.506 |
| BMI (kg2/m2) | 24.93 (4.42) | 26.29 (4.64) | 0.534 |
| CRP (mg/L) | 17.88 (27.06) | 32.56 (50.44) | 0.453 |
| Cancer type | Pancreatic – 1 | Pancreatic – 6 | N/A |
| Oesophageal – 6 | Oesophageal – 2 | ||
| Gastric - 2 | Duodenal - 1 | ||
| Disease stage | 1 (n = 1) | 1 (n = 1) | |
| 2 (n = 0) | 2 (n = 5) | ||
| 3 (n = 6) | 3 (n = 1) | ||
| 4 (n = 1) | 4 (n = 2) | ||
| Unknown (n = 1) | - | ||
| Pre-operative chemotherapy | 4 | 2 | N/A |
All data are mean (standard deviation). SMI—Skeletal muscle index, SATI—subcutaneous adipose tissue index, VATI—Visceral adipose tissue index, BMI—Body mass index, CRP = C Reactive protein. * Denotes statistically significant result.